Esperion Therapeutics Inc. (ESPR)
Market Closed
14 Jul, 20:00
$
3. 18
0
0%
$
661.15M Market Cap
- P/E Ratio
- Div Yield
59.09M Volume
-1.97 Eps
$ 3.18
Previous Close 
Want to track ESPR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Esperion Therapeutics Inc. (ESPR) Statistics
Valuation metrics
Market Cap 661.15M
Enterprise value 1.05B
Trailing P/E (ttm) -131.4
Forward P/E 10.68
PEG ratio -0.4
Price/Sales (ttm) 1.58
Price/Book (mrq) -2.6
Enterprise Value/Revenue 2.51
Enterprise Value/EBITDA 26.29
Overview
Shares outstanding 245.22M
Float 255.18M
Shares short 36.43M
% Held by insiders 0.01%
% Held by institutions 0.7%
Average volume (10 days) 58.42M
Average volume (90 days) 16.48M
Price summary
52-Week low 1.1
52-Week high 4.18
Beta 0.91
50-Day moving average 3.16
200-Day moving average 2.96
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 3.16
Trailing annual dividend yield 0.9937%
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 11 Jun 2013
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.02%
Operating margin 0.18%
Operational effectiveness
Return on assets -0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) 418.24M
Revenue per share (ttm) 1.66
Quarterly revenue growth (yoy) 0.23%
Gross profit (ttm) 241.7M
EBITDA 63.87M
Net income to common (ttm) -7.42M
Diluted EPS (ttm) -0.03
Quarterly earnings growth (yoy) 1.44%
Balance Sheet
Total cash (mrq) 156.16M
Total cash per share (mrq) 0.62
Total debt (mrq) 543.81M
Total Debt/Equity (mrq) -1.77
Current ratio (mrq) 1.53%
Book value per share (mrq) -1.23
Cash Flow
Cash flow statement -18.19M
Levered free cash flow (LFCF) -49.71M
